Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.70 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.70 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.70 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.70 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8520521 | 0.97 | CYP3A4 (0.74) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL1914011 | 0.97 | CYP3A4 (0.74) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL12098532 | 0.97 | CYP3A4 (0.74) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL15773413 | 0.87 | CYP3A4 (0.61) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL2757490 | 0.87 | CYP3A4 (0.87) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL9912032 | 0.87 | CYP3A4 (0.87) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL15393063 | 0.87 | CYP3A4 (0.60) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL6126701 | 0.87 | CYP3A4 (0.60) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL24784512 | 0.86 | CYP3A4 (0.75) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL17011892 | 0.86 | CYP3A4 (0.59) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3239153-A1 | 9-(1H-IMIDAZOL-5-YL)-1,11-DIHYDROISOCHROMENO[4',3':6,7]NAPHTHO[1,2-D]IMIDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF HCV NS5A | Gilead Pharmasset LLC (US) | 2017-11-01 | — | — | EP | disclosed |